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In many African countries the burden of preventable communicable diseases such as 
HIV/AIDS, lower respiratory infections, malaria and diarrhoeal diseases is overwhelming [1]. 
It therefore is no surprise that moving rheumatic and musculoskeletal disease (RMDs) up the 
public health agenda is difficult. The health needs of the African continent are complex and 
diverse, but priority setting is challenging in an environment hampered by financial 
constraints and limited epidemiological data. This can be further complicated by lack of 
resources and donor-dependent economies [2].   
 
Taking these factors into account, it is not an easy task to engage public health systems 
across Africa to include rheumatic and musculoskeletal disease (RMDs) on their list of health 
priorities. Yet, the burden of RMDs has shown a marked increase and now has a truly global 
impact. Although the epidemiology data in Africa are limited, RMDs have the fourth largest 
impact on the health of the world’s population, when considering both death and disability 
(DALYs), and are the second most common cause of disability worldwide when measured by 
years lived with disability (YLDs)[3, 4]. As the world population ages and obesity is on the rise, 
this burden is set to increase further.  
 
Onset of RMDs, however, often occurs in the working age population, so failing to effectively 
treat RMDs has a socioeconomic impact both at the individual and societal level. Losing 
employment through illness has a double effect on a family, who not only lose income but 
need to increase their expenditure to meet associated healthcare costs. 
 
Data from the UK indicates that as many as a third of patients with rheumatoid arthritis (RA) 
become unemployed within the first five years of their diagnosis, with rates highest in those 
with higher level of physical disability or manual jobs [5]. The economic impact of losing 
experienced workers from RMDs should not be underestimated in Africa, where there are 
higher rates both of manual work and disability [6]. Failing to effectively treat RMDs now, or 
to develop a health workforce capable of dealing with a likely future increase in the number 
of people with RMDs, will further impede Africa’s economic development over the coming 
years.  
 
Although some of these challenges can be met by increasing health spending, where this is 
not possible, much can also be achieved by using the scarce health resources in new ways 
[2](WHO, 2014).   
 
The growing burden of RMDs is juxtaposed with our increasing effectiveness in treating these 
conditions: we’re now better able to influence patient outcomes than ever before. For 
example in rheumatoid arthritis (RA), treatment is now aimed at remission [7], once 
considered unachievable.  Progress has been most pronounced in inflammatory arthritis and 
stems from the paradigm shift towards identifying patients early, initiating effective 
therapies within three months of symptom onset, regular disease assessment and 
maintaining tight disease control. Whilst few would disagree with the benefits of the current 
paradigm, there is a clear challenge for under-resourced health systems to deliver this model 
of care on a population level [6]. Indeed the challenge of finite resources, greater patient 
need, and rising treatment costs is one that faces health systems across the world. Yet, this is 
a challenge that we must all meet if we are to improve the quality of life for our patients and 
minimise the economic burden of RMDs.  
 
Within the UK health system, care is free at the point of delivery but health spending; the 
healthcare workforce; and the healthcare system’s architecture have struggled to meet the 
needs of a modern population. This problem is not new, and in the 1990s a growing shortage 
of doctors led to a corresponding gap in service delivery. This crisis signalled the start of an 
ongoing journey. The roles of nurses and allied health professionals (AHPs) had to expand to 
fil some of these gaps through new extended scope roles, to deliver tasks that were 
traditionally the preserve of doctors. This change did not occur overnight, and much work 
was required to change legislative frameworks to allow such roles to develop safely and 
effectively. Nurses were the first to pioneer advanced roles [8] and now highly trained nurse 
specialists have a range of skills such as joint injections and prescription rights [8, 9]. As care 
for people with RMDs evolves so do these roles and there is now evidence from high quality 
multicentre randomised controlled trials which demonstrates that nurse led care is cost 
effective, safe and patients report higher levels of satisfaction than they do in traditional 
medically led models of care [10]. Such has been the success of nurse specialists, that they 
are now an essential part of every rheumatology services in the UK and elsewhere in Europe 
[11-14], where they work collaboratively with rheumatologists, within the framework of a 
multidisciplinary team, rather than in competition.  
 
In Europe, much has been achieved by offering early access, regular disease assessment and 
patient education using a strong team approach, with nurses and AHPs advancing their skills 
to enhance the care provided by the medical team.   This allowed for a larger volume of 
patients to be seen and managed safely. This team approach has served to optimise the role 
of the rheumatologist and enable the services to deliver more cost effective care. For 
example, some clinics now use specialist nurses to coordinate care and undertake routine 
patient monitoring, freeing the rheumatologist’s time to deal with new and more complex 
cases. Such an approach would represent a logical progression in Africa where non-physician 
providers such as medical assistants and assistant medical officers have been used effectively 
for many years within their healthcare systems with great effect [15]. 
 
Advanced nursing practice is established in the UK but in different stages of development 
across Europe [14]. In other parts of the world such as in Asia, nurses are now starting this 
journey and have recently endorsed rheumatology nurses as a specialist area of practice with 
appropriate training [16]. Each country must develop a solution to meet the specific 
challenges it faces utilising the differing resources at it’s disposal. By learning from the reality 
of patients’ experiences of seeking health, healthcare communities will learn where we can 
most effectively optimise care and reduce costs. Although a ‘one size fits all’ approach is 
unlikely to work, our experience has shown there are some common obstacles to overcome 
when starting this journey, and indeed many of these reoccur over time as administrations 
change. Training nurse and AHP workforces to meet this clinical need requires changes in 
legislation, investment, and a cultural change from all within healthcare so that clinical need 
and patients outcomes and safety come before traditional professional boundaries and 
personal interests.  
 
Developing services in such a way does not happen overnight and needs to be managed in a 
stepwise approach and although individuals are key to the process, it cannot be achieved 
alone. National and continental bodies are vital with regards to the political agenda but 
individuals have a responsibility to foster a culture where development of nurses and AHPs is 
welcomed and encouraged in order to improve care. The wider healthcare workforce should 
be valued and developed in order to ensure sustainable health services. Similarly, individual 
nurses and AHPs have a responsibility to take ownership of their own development and 
maximise opportunities when they present. The global rheumatology community should 
work collaboratively to support each other in developing care for people with RMDs. One 
example of this has recently been afforded through the British Society of Rheumatology 
(BSR) who for the first time, provided two bursaries through the African League Against 
Rheumatism. These bursaries provide funding for one rheumatologist (Dr Joan Dellor 
bursary) and one nurse (The BSR Nursing Travel Bursary) to attend the annual BSR 
conference and to then spend time in a leading rheumatology unit. The annual conference 
not only contains highlights from world leading researchers, practical sessions, and a range of 
networking opportunities but also enables clinicians and researchers to discuss challenges in 
delivering care as well as sharing ideas on implementing the latest research findings.  Sharing 
such opportunities internationally provides a vital link between the United Kingdom and 
Africa and it is hoped that the bursaries may make some small step towards stronger 
collaboration.   
 
Addressing the growing burden of RMDs is a challenge that Africa must embrace and 
overcome in the coming years. As the saying goes: ‘he who keeps a healthy cow will have 
plenty of milk’, training the workforce is not a waste of resources.  Some countries have 
already started down this journey and found great benefit in growing the nursing and AHP 
specialist workforce. This journey is achievable and likely to be rewarding. Although it may 
take many years, small steps are needed at the start. Could the new bursaries be the first 
step of your journey?   
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